Expert Review of Anti-Infective Therapy

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	205
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	88
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	71
Neonatal ocular prophylaxis in the United States: is it still necessary?	62
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	61
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	60
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	60
Challenges in preserving antibiotic effectiveness: time for a novel approach	49
Visceral leishmaniasis elimination in India: progress and the road ahead	46
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	42
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	41
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	39
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	38
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	37
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	36
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	35
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	34
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	33
Tineas caused by hedgehogs due to Trichophyton erinacei an ascending agent of dermatophytosis	33
Hypoalbuminemia as a predictor of severe dengue: a systematic review and meta-analysis	31
IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients	30
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	29
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	27

Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	26
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	25
The rationale for including osteopathic manipulative treatment in the management of infections: a hermeneutic review	24
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	23
Treatment of vaginitis caused by non-albicans Candida species	22
Reemergence of monkeypox: prevention and management	21
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline	21
The ongoing challenge of prevention of pertussis in infants: what’s new in 2024?	20
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy	20
Direct or early Discharge of Acute Bacterial Skin and Skin Structure Infection patients from the Emergency Department/Unit: place in therapy of dalbavancin	19
Diagnostic and clinical management of Candida auris infections in immunocompromised patients	18
Predicting the limit to ceftriaxone’s use in gonorrhea treatment: impending resistance and logistical challenges	17
Prevention of viral infections in solid organ transplant recipients in the era of COVID-19: a narrative review	17
Infliximab as a potential treatment for COVID-19	17
Diagnostic and management strategies for chronic hepatitis E infection	17
Clinical efficacy of nirmatrelvir plus ritonavir in patients with COVID-19 and preexisting cardiovascular diseases	16
Analysis of bacterial spectrum and construction of a predictive model for postoperative sepsis in patients with upper urinary calculi and positive urinary cultures	16
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19	16
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance	16
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases	16
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	16
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review	15
In vitro and in vivo activity of meropenem+avibactam against MBL-producing carbapenem-resistant Klebsiella pneumoniae	15
Correction	15
Nintedanib: a review of the properties, function, and usefulness to minimize COVID-19-induced lung injury	15
Challenges, risks, and opportunities of antiretroviral drugs in women of reproductive potential	15
The opportunities and challenges of epigenetic approaches to manage herpes simplex infections	14
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	14
Statement of Retraction	14
Diagnosing fungal infections in clinical practice: a narrative review	14
Predictors and patterns of empirical antibiotic therapy and associated outcomes in COVID-19 patients: a retrospective study in a tertiary care facility in South India	14
The serological dilemma: rethinking syphilis treatment evaluation	14
Ceftazidime-avibactam and aztreonam combination for Carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-β-lactamase production: a systemat	13
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	13
Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review	13
Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana	13
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection	13
Low-risk penicillin allergy delabeling: a scoping review of direct oral challenge practice, implementation, and multi-disciplinary approaches	13
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers?	13
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations	13
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?	12
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas	12
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study	12
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	12
An overview of potential combination therapies with ceftriaxone as a treatment for gonorrhoea	12
Monoclonal antibodies for the treatment of COVID-19 infection in children	12
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae	12
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan	12
The evolving scenario of HCV-related mixed cryoglobulinemia and B-cell lymphoma in the era of direct-acting antivirals	11
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	11

The rise of mucormycosis in Covid-19 patients in India	11
How can we tackle the overuse of antibiotics in low- and middle-income countries?	11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	11
How do we best manage Clostridioides difficle infections in the elderly?	10
Clinical outcomes, virological efficacy and safety of nitazoxanide in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	10
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis	10
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study	10
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review	10
Gram-positive infections in special populations. Expert view on the role of dalbavancin	10
Now that griseofulvin is not available, what to do with tinea capitis treatments?	10
Tocilizumab for the treatment of COVID-19	10
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers	10
New insights into the treatment of acute otitis media	9
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients	9
Comparison of clinical outcomes of antibiotics used for Staphylococcus aureus bacteremia in pediatric patients	9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America	9
Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?	9
Clinical efficacy of probiotics in the treatment of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials	9
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	9
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agents	9
Update on actinomycetoma treatment: linezolid in the treatment of actinomycetomas due to Nocardia spp and Actinomadura madurae resistant t	9
Artificial intelligence and prescription of antibiotic therapy: present and future	9
Synergistic effect of eravacycline combined with fluconazole against resistant Candida albicans in vitro and in vivo	8
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria	8
Ivermectin: a pathway out of the pandemic or another dead end?	8
Global importance of new treatment strategies to efforts to control hepatitis B virus	8
RETRACTED ARTICLE: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	8
Host defense mechanisms against Candida auris	8
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	8
Strengths and caveats of identifying resistance genes from whole genome sequencing data	8
Understanding mechanisms of virulence in MRSA: implications for antivirulence treatment strategies	8
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	8
Diagnosis, prevention, and treatment of coronavirus disease: a review	8
Metallo-beta-lactamases: mechanisms, treatment challenges, and future prospects	8
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical	8
Efficacy and safety of eravacycline (ERV) in treating infections caused by Gram-negative pathogens: a systematic review and meta-analysis	8
Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19	8
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	8
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan	8
An update on newer antifungals	8
Effect of tixagevimab/cilgavimab for pre-exposure prophylaxis during the China Omicron outbreak	8
Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options	8
Past, present, and future perspectives on aztreonam and avibactam	8
High frequency and molecular characterization of ESBL-producing Enterobacteriaceae isolated from wound infections in North Lebanon	7
A systems thinking approach for antimicrobial stewardship in primary care	7
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV	7
Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow	7
Can probiotics replace antibiotics? Not yet, says the evidence	7
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies	7
Unveiling the potential role of micro/nano biomaterials in the treatment of Helicobacter pylori infection	7
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	7
The war against bacteria, from the past to present and beyond	7
HTLV-I associated bronchioloalveolar disorder (HABA): disease concept and differential diagnosis of an unsolved disease entity	7
Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?	7
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose	7
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	7
The prevalence of antimicrobial drug resistance of non-typhoidal Salmonella in human infections in sub-Saharan Africa: a systematic review and meta-analysis	7
Containment strategies for COVID-19 in India: lessons from the second wave	7
Introduction and spread of NDM-producing Enterobacterales and Acinetobacter baumannii into Middle Eastern countries: a molecular-based hypothesis	7
Non-cancerous complications in HTLV-1 carriers	7
Safety and efficacy of new generation azole antifungals in the management of recalcitrant superficial fungal infections and onychomycosis	7
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	6
Gram-negative blood stream infections: prospects and challenges of rapid antimicrobial susceptibility testing	6
Phage therapy in pediatrics: the way forward for difficult-to-treat infections?	6
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	6
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?	6
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation	6
The potential of 4D’s approach in curbing antimicrobial resistance among bacterial pathogens	6
Brucellosis control methods with an emphasis on vaccination: a systematic review	6
Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship	6
Langya henipavirus outbreak	6
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis	6
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better	6
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China	6
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials	6
How do we change our approach to COVID with the changing face of disease?	6
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)	6
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	6
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain	6
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status	6

Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates	6
The effects of the pandemic in cases of heart failure	5
Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years	5
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	5
Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice	5
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) in Canada: treatment update and the role of new IV antimicrobials	5
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis	5
Letter to the Editor: the earliest observation of bla NDM was in Israel	5
Prevalence of antibiotic resistance in clinical isolates of Mycobacterium kansasii : a systematic review and meta-analysis	5
Management of calcified cysticerci in the brain parenchyma: treating the dead parasite	5
Omadacycline in treating community-based infections: a review and expert perspective	5
Mechanisms of resistance to cell wall and plasma membrane targeting antifungal drugs in Candida species isolated in Africa	5
Development of antiviral drugs for COVID-19 in 2025: unmet needs and future challenges	5
The association between neutrophil to lymphocyte ratio and endothelial dysfunction in people living with HIV on stable antiretroviral therapy	5
Real-world implementation of dolutegravir plus lamivudine in people living with HIV in Southwest China	5
Candida auris biofilm: a review on model to mechanism conservation	5
Association of outpatient fluoroquinolone prescribing with the National Medical Products Administration announcements of label changes in China	5
Associations of infection control measures and norovirus outbreak outcomes in healthcare settings: a systematic review and meta-analysis	5
A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials	5
Artificial intelligence and its application in clinical microbiology	5
Efficacy and safety of vitamin D in tuberculosis patients: a systematic review and meta-analysis	5
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	4
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution	4
Antibiotic resistance in low- and middle-income countries: current practices and its global implications	4
The effect of intravenous immunoglobulins on the outcomes of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	4
Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States	4
New therapeutic strategies for Mycobacterium abscessus pulmonary diseases – untapping the mycolic acid pathway	4
Impact of successful HCV treatment using direct acting antivirals on recurrence of well ablated hepatocellular carcinoma	4
Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials	4
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae	4
Antibiotic use among hospitalized children with lower respiratory tract infections: a multicenter, retrospective study from Punjab, Pakistan	4
Advantages and limitations of current diagnostic laboratory approaches in syphilis and congenital syphilis	4
Managing sepsis in the era of precision medicine: challenges and opportunities	4
Tixagevimab/cilgavimab for prevention and treatment of COVID-19: a review	4
Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis	4
Secnidazole: a treatment for trichomoniasis in adolescents and adults	4
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study	4
Immunocompromised patients and COVID-19: how do we protect those most at risk?	4
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal againstHelicobacter pylori	4
False-positivity results in rapid antigen tests for SARS-CoV-2: an umbrella review of meta-analyses and systematic reviews	4
The efficacy and safety of hydroxychloroquine at different doses and courses for COVID-19 prevention: a systematic review and network meta-analysis	4
Assessment of rationality of available fixed dose combinations of antibiotics in India	4
Comparison of dolutegravir+Lamivudine and bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral therapy-naïve patients infected with HIV: preliminary results from clinical practice	4
Personalized care approaches to hepatitis C therapy: recent advances and future directions	4
Nirmatrelvir/ritonavir: real world drug–drug interaction management experience	4
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	3
The antifungal pipeline for invasive fungal diseases: what does the future hold?	3
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy	3
Ursodeoxycholic acid and COVID-19 outcomes: a cohort study and data synthesis of state-of-art evidence	3
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses	3
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China	3
Understanding Staphylococcus aureus internalisation and induction of antimicrobial tolerance	3
Current role of ceftobiprole in the treatment of hospital-acquired and community-acquired pneumonia: expert opinion based on literature and real-life experiences	3
Doxycycline post-exposure prophylaxis as prevention of STIs – the golden bullet?	3
Efinaconazole topical solution (10%) for the treatment of onychomycosis in adult and pediatric patients	3
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge	3
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread	3
Biosimilars as antivirals: opportunities and challenges	3
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections	3
Concerns with current Drug Laws regarding the purchasing antibiotics without a prescription in Pakistan; ways forward to assist the national action plan	3
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	3
Could the next disease X be pandemic of virus-induced encephalitis? what should be our first medical response?	3
Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications	3
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review	3
Statement of Retraction: Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial	3
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	3
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice	3
Therapeutic strategies to address monkeypox	3
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	3
The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants	3
Therapeutic potential of 5-aminolevulinic acid and sodium-ferrous citrate for viral insults: relevance to the COVID-19 crisis	3
Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotic prophylaxis and empirical treatment	3
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?	3
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	3
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities	3
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	3
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?	3
Meropenem-vaborbactam: a critical positioning for the management of infections by Carbapenem-resistant Enterobacteriaceae	3
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?	3